2m 2m 2m 2m 2m 2m 2m
Belite Bio Sp ADR (BLTE)
NASDAQ
$145.35-$1.72 (-1.17%)
Price as of Jun 23, 2026 4:10 PM EDT- $5.9BMarket Cap
- 139.14%1-Year Change
- BiotechnologyIndustry
Belite Bio Sp ADR (BLTE)
$145.35-$1.72 (-1.17%)
BLTE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $147.07 | ||
Change | +$0.95 (+0.65%) | ||
Open | $147.63 | ||
High | $150.00 | ||
Low | $144.79 | ||
Previous Close | $146.12 | ||
Volume | 172,445 | ||
30-Day Average Volume | 268,401 | ||
1-Week Change | 1.96% | ||
1-Month Change | 7.12% | ||
1-Year Change | 139.14% | ||
3-Year Change | 1,098.61% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 40.1M | ||
Total Assets | $780.6M | ||
Market Cap | $5.9B | ||
Enterprise Value | $5.5B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue